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Abstracts / International Journal of Surgery 36 (2016) S31eS132 S127From April 2013, pre-procedural USS was carried out on each patient
attending for SPC insertion. Patients with overlying bowel were referred
for open insertion.
Result: 322 SPCs were inserted between July 2008 e April 2013 without
the routine use of pre-procedural USS. 101 were inserted between May
2013- June 2015 with USS guidance.
Following the introduction of USS, there were no recorded cases of bowel
perforation associated with SPC insertion (Without USS 3/322, 0.9%, with
USS 0/101, 0%). Referrals for open insertion increased (Without USS 7/322
(2.6%), with USS 12/101 (12%)).
Conclusion: In our clinic, use of pre-procedural USS has eliminated the
risk of associated bowel perforation, with an appropriate increase in re-
ferrals for open insertion.
Dedicated SPC clinics provide a safe and effective service for SPC insertion
with excellent opportunities for training.http://dx.doi.org/10.1016/j.ijsu.2016.08.472
0962: IS THERE A ROLE FOR ORCHIDECTOMY IN THE MANAGEMENT OF
REFRACTORY CHRONIC TESTICULAR PAIN
H. Garrod*, G. Brown. Royal Glamorgan Hospital, Llantrisant, UK.
Aim: Chronic testicular pain represents a difﬁcult challenge for the urol-
ogist and has a varied aetiology. Around 25% of patients will not have a
cause identiﬁed for their symptoms but continue to experience debili-
tating pain. When pain is refractory to pharmaceutical treatment, patients
may be referred for consideration of orchidectomy. We aim to assess the
effectiveness of this procedure.
Method: Eight patients who underwent an orchidectomy for chronic
testicular pain were retrospectively reviewed. A telephone follow-up was
conducted to assess post-operative pain outcomes.
Result: Average age was 44 years. 88 % said their pain improved, 62 %
reorted complete resolution. The mean improvement in all patients was
65%. Only one patient felt there had been no improvement in their pain.
There was no consistent singular histological ﬁnding although half of pa-
tients showed evidence of ﬁbrosis or atrophy. One patient felt that their
pain had not improved and felt there had been additional sexual and
psychological problems that outweighed the beneﬁts of surgery.
Conclusion: This study supports other data that orchidectomy is an
effective treatment in refractory chronic testicular pain. Careful patient
selection is paramount and further research is required to identify patients
most likely to beneﬁt from this procedure.http://dx.doi.org/10.1016/j.ijsu.2016.08.473
0970: SURGICAL OUTCOME ANALYSIS OF 130 CONSECUTIVE PARTIAL
NEPHRECTOMIES UNDERTAKEN IN THE SOUTH WALES REGION AND
COMPARISON WITH BAUS (STUKA) DATA
D. Teichmann 1,*, L. Whitehurst 1, R. Chaytor 2, I.l Omar 3, O. Naser 3,
M. Kamarizan 4, A. Carter 4, S. Moosa 3, K. Narahari 1, R. Coulthard 1,
N. Fenn 2. 1University Hospital of Wales, Cardiff, UK; 2Morriston Hospital,
Swansea, UK; 3Glangwili General Hospital, Carmarthen, UK; 4Royal Gwent
Hospital, Newport, UK.
Aim: Partial Nephrectomy is an increasingly popular technique for man-
aging small renal tumours both via an open and laparoscopic approach.We
wished to compare our regional numbers, approaches and complication
rates to the nationally published BAUS STUKA audit
Method: We performed a retrospective case-note analysis across 4
regional centres of 130 consecutive partial nephrectomies between the
years of 2011-2015. We examined patient demographics, surgical
approach, operation time, blood loss, warm/cold ischaemia time, tumour
histology, margin positivity, length of stay and complication rates as
classiﬁed by the Clavien-Dindo system (CD)
Result: Our results compare favourably with the STUKA audit in the do-
mains of post-operative complications as classiﬁed by CD 2-5 (10% vs 13%).
A lower percentage of cases are done laparoscopically (14% vs 24% na-
tionally) despite tumour size distribution being similar. Margin positivitywas similar laparoscopically (5.5%), although higher than the national
average in open cases (10.7% vs 5%). Malignant disease was 6% lower (81%
vs 87%) and benign disease was 7% higher (11% vs 18%). There were no
patient deaths and no recorded recurrences at present.
Conclusion: We believe this practice evaluation provides the foundation
for service development. Varied numbers between units favour central-
isation of care thus allowing development in laparoscopic techniques
including the recently acquired robotic service.http://dx.doi.org/10.1016/j.ijsu.2016.08.474
1039: SHOULD WE RECONSIDER RUSHING TO CONVERT NEPHROSTO-
MIES TO ANTEGRADE STENTS IN THE PALLIATIVE SETTING?
L. Chandra*, P. Hughes, M. Kimuli. Leeds Teaching Hospitals Trust, West
Yorkshire, UK.
Introduction: The management of ureteric obstruction in the palliative
care setting is potentially challenging. Clinicians often deliberate long and
hardwith patients and family regarding the implications of their prognosis
and the role of nephrostomies in alleviating renal failure. However, sub-
sequent conversion to an antegrade stent is often regarded as a default
procedure, but perhaps may not always appropriate for patients with very
limited lifespans.
Method: We performed a retrospective review of all antegrade stents
inserted (2011-14) as a consequence of malignancy within our institution.
Demographics, primary malignancy, disease stage and treatments to date
were detailed along with survival duration post stent insertion.
Result: 73.5% of patients receiving ‘best supportive care' died within 90
days of antegrade stent insertion. For patients receiving curative or palli-
ative treatment this was only 12.5% and 21% respectively.
Conclusion: Recognising the limited lifespan that patients considered for
best supportive care have, clinicians should consider the need and
appropriateness of a second invasive procedure to insert an antegrade
stent. This study can help inﬂuence quality of life discussions with patients
who face the ﬁnal phases of their lives.http://dx.doi.org/10.1016/j.ijsu.2016.08.475
1163: THE INTRODUCTION OF MULTIPARAMETRIC MRI IN PROSTATE
CANCER MANAGEMENT: DOES IT AID THE UROLOGIST?
D. Loughran*, D. Teichmann, P. Bose, J. Featherstone, S. Davies, R. Evans,
N. Fenn. Morriston Hospital, Swansea, UK.
Aim: NICE prostate cancer guidelines recommend the use of multi-para-
metric MRI in patients undergoing i) active surveillance or ii) those with a
raised PSA wishing to avoid initial or repeat biopsy. We examine man-
agement outcomes in these groups following the introduction of our new
3T mpMRI Service.
Method: Patients were categorised as either; being on or considered for
Active Surveillance (n¼29), or patients being investigated for a raised PSA,
either biopsy naïve (n¼11) or with previous biopsies (n¼13).
Result: In the ‘active surveillance’ group, mpMRI allowed 83% (n¼24) to be
reassured of low volume disease with 10% (n¼3) requiring further inves-
tigation with a targeted biopsy (7%, n¼2) or bone scan (3%, n¼1) Two
patients underwent deﬁnitive management in the form of EBRT and
recruitment to a HIFU trial.
In the ‘biopsy naive’ group (n¼11), 10 were reassured and 1 underwent
targeted biopsy.
In the ‘previous biopsy group’ (n¼13), 10 were reassured, 2 underwent
targeted biopsy, the last was inconclusive due to THR's.
Conclusion: Adoption of NICE guidance on mpMRI indications allowed
evidence based decisions to be made regarding maintenance of AS, pre-
vention or initiation of targeted biopsy, or active treatment.http://dx.doi.org/10.1016/j.ijsu.2016.08.476
